Tp10    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
223Primary membranoproliferative glomerulonephritis1

223. Primary membranoproliferative glomerulonephritis    [ 18 clinical trials,   14 drugs,   (DrugBank: 7 drugs),   7 drug target genes,   14 drug target pathways]
Searched query = "Primary membranoproliferative glomerulonephritis", "Dense deposit disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 18 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02302755
(ClinicalTrials.gov)
November 20145/11/2014TP10 Use in Patients With C3 Glomerulopathy (C3G)A Pilot, Open-Label Single Center Trial of TP10 in Pediatric and Adult Patients With C3 Glomerulopathy (C3G)Dense Deposit DiseaseDrug: TP10University of IowaNULLWithdrawn4 YearsN/ABoth0Phase 1United States